Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities

Figure 4 Overview of the main methodology used to change the name of fatty liver disease. The conclusions reached at each round of the Delphi method are shown on the right. Changes were also made in the diagnostic criteria (not shown here). An independent subcommittee comprising expert hepatologists, endocrinologists, pediatricians, and patients chose between the top three acronyms emerging from the fourth Delphi round. SLD: Steatotic liver disease; MASLD: Metabolic dysfunction-associated SLD; MASH: Metabolic dysfunction-associated steatohepatitis; MetALD: MASLD, and moderate alcohol intake.